 4. Pathological Complete Response pCR following a neo-adjuvant chemotherapy CT and trastuzumab for stage II-III patients only. pCR is defined as no evidence of residual invasive carcinoma in the breast ductal carcinoma in situ DCIS is allowed AND in all the examined lymph nodes micro-metastases and isolated tumour cells are not allowed. 